THE USE OF FIBRIN SEALANT FOR EMBRYO TRANSFER - DEVELOPMENT AND CLINICAL-STUDIES

被引:27
作者
FEICHTINGER, W
STROHMER, H
RADNER, KM
GOLDIN, M
机构
[1] Institute for Sterility Treatment, A-1130 Vienna
关键词
ECTOPIC PREGNANCY; EMBRYO TRANSFER; FIBRIN SEALANT; IVF;
D O I
10.1093/oxfordjournals.humrep.a137756
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Many embyro transfers after in-vitro fertilization may fail because of expulsion of the embryos from the uterus. Approximately 5 - 8% of pregnancies resulting from embryo transfer are ectopic. The aim of our study was to rind a technique to avoid ectopic pregnancies and to improve the pregnancy rate. We used a two-component fibrin sealant which also contains a fibrinolysis inhibitor (aprotinin) at various concentrations. After gaining experience with mouse embryos, the sealant was used in human embryo transfer with great success. The results of a pilot study encouraged us to perform a prospective randomized study on 546 patients (270 with fibrin sealant, 276 conventional embryo transfers). There were 47 (17.0%) orthotopic pregnancies and 6 (2.2%) ectopic pregnancies in the control group, whereas there were 51 (18.9%) intrauterine and no ectopic pregnancies in the treatment group. The difference in ectopic pregnancies was statistically significant (P < 0.05). With regard to the aprotinin concentration, there was a trend towards better results with 100- 150 kIU (28.5% clinical pregnancies) in comparison to 250 - 300 kIU (19.2%) or no aprotinin (20.4%) (not significant). Further improvements of the technique may raise the pregnancy rate when fibrin sealant is used. As shown in our prospective randomized study, ectopic pregnancies may be completely avoided.
引用
收藏
页码:890 / 893
页数:4
相关论文
共 11 条
[1]  
Cohen J., Mayaux M.J., Guihard-Moscato M.L., Schwartz D., N-vitro fertilization and embryo transfer: A collaborative study of 1163 pregnancies on the incidence and risk factors of ectopic pregnancies, Hum. Reprod, 1, (1986)
[2]  
De Vries K., Lyons E.A., Ballard G., Levi C.S., Lindsay D.J., Contractions of the inner third of the myometrium, Am, J. Obstet. Gynecol, 162, (1990)
[3]  
Englert Y., Puissant F., Camus M., Van Hoeck J., Testart J., Frydman R., Leroy F., Conditions du transfert intrautdrin et devenir des embryons, Rev. Mid. Brux, 6, pp. 615-620, (1985)
[4]  
Feichtinger W., Barad D., Feinman M., Barg P., (, Fertil. Steril, 54, (1990)
[5]  
Kemeter P., Feichtinger W., Experience with a new fixed- stimulatkm protocol without hormone determinations for programmed oocyte retrieval for in vitro fertilization, Hum. Reprod, 4, pp. 53-58, (1989)
[6]  
In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET Registry, Fertil. Steril, 55, pp. 14-23, (1991)
[7]  
Redl H., Schlag G., Fibrin sealant and its modes of application, Fibrin Sealant in Operative Medicine, Gynecology and Obstetrics-Urology, 3, (1986)
[8]  
Rodrigues F.A., Van Rensburg J., De Vries J., Sonnendecker E., The effect of fibrin sealant on mouse embryos, J. In Vitro Fertil. Embr, 5, pp. 158-160, (1988)
[9]  
Rossin-Amar B., Chinchole J.M., Tourame P., Valette J.C., Bouchard P., Compensation of observed aspiration during the catheter withdrawal. Abstracts of VI, World Congress of in Vitro Fertilization and Alternate Assisted Reproduction, (1989)
[10]  
Schulman J.D., Delayed expulsion of transfer fluid after IVF/ET, Lancet, 1, (1986)